Antineoplastics/methylprednisolone/netupitant/palonosetron

Various toxicities: 4 case reports

    This is a preview of subscription content, log in to check access.

    Notes

    1. 1.

      "Demographic details of all patients (22-year-old man, 41-year old woman, 61-year-old woman and 33-year-old woman) were obtained through personal communication with the author."

    Reference

    1. Zilioli VR, et al. Safety and efficacy of netupitant/palonosetron and dexamethasone in classical Hodgkin's lymphoma patients with inadequate chemotherapy-induced nausea and vomiting prophylaxis with palonosetron and dexamethasone: A single-center real-life experience. International Journal of Hematologic Oncology 9: 286, No. 1, Mar 2020. Available from: URL: http://doi.org/10.2217/ijh-2020-0001

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Antineoplastics/methylprednisolone/netupitant/palonosetron. Reactions Weekly 1809, 45 (2020). https://doi.org/10.1007/s40278-020-79829-6

    Download citation